Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group-Reference-Cited by-同舟云学术

Long-term survey of survival time, histological transformation, and secondary malignancies in Japanese patients with advanced-stage follicular lymphoma in the rituximab era: Hokkaido Hematology Study Group

Published:2014-07-23 Issue:3 Volume:100 Page:281-289
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Hirayama Yasuo,Ishitani Kunihiko,Ota Shuithi,Kurosawa Mitsutoshi,Kondo Takeshi,Takimoto Rishu,Mori Akio,Sakai Hajime,Torimoto Yoshihiro,Yamamoto Satoshi,Sato Kazuya,Iwasaki Hiroshi,Kohda Kyuhei,Ishida Tadao,Kakinoki Yasuhiro,Fukuhara Takashi,Kato Junji

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/content/pdf/10.1007/s12185-014-1629-4.pdf

Reference37 articles.

1. The non-Hodgkin’s lymphoma Classification Project. A clinical evaluation of International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89:3909–15.

2. Lymphoma study group of Japanese pathologists. The world health organization classification of malignant lymphomas in japan: incidence of recently recognized eitities. Pathol Int. 2000;50:696–702.

3. Hiddemann W, Kneba M, Dreyling M, Schmitz N, Lengfelder E, Schmits R, et al. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group. Blood. 2005;106:3725–32.

4. Marcus R, Imrie K, Solal-Celigny P, Catalano JV, Dmoszynska A, Raposo JC, et al. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma. J Clin Oncol. 2008;26:4579–86.

5. Swenson WT, Wooldridge JE, Lynch CF, Forman-Hoffman VL, Chrischilles E, Link BK. Improved survival of follicular lymphoma patients in the United States. J Clin Oncol. 2005;23:5019–26.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness study of chemotherapy in follicular lymphoma patients in the rituximab era: a Japanese claims database study;Future Oncology;2021-02

2. Incidence of solid cancer in patients with follicular lymphoma;Acta Oncologica;2019-08-01

3. BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma;Leukemia & Lymphoma;2018-11-27

4. Burden of illness of follicular lymphoma and marginal zone lymphoma;Annals of Hematology;2018-10-13

5. Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma;Journal of Clinical Oncology;2018-03-01